The S configuration for chiral center 3* is decisive for high bioactivity; the chirality effect of chiral center 2* on binding affinity is largely dependent, while the S configuration for 2* is preferable to R for bioactivity gain; the chirality specificity for chiral center 11b* to binding affinity is insignificant.